BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Finance Desk//Catalysts//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Finance Desk catalysts
X-PUBLISHED-TTL:PT1H
REFRESH-INTERVAL;VALUE=DURATION:PT1H
BEGIN:VEVENT
UID:fd-catalyst-2536@financedesk
DTSTAMP:20261013T222538Z
DTSTART;VALUE=DATE:20270101
SUMMARY:Retatrutide BLA submission to FDA (planned Q1 2027) (est.)
DESCRIPTION:Estimated date.\nRetatrutide\, Eli Lilly\, LLY\nhttps://www.wi
 remeridian.com/c/eli-lilly/retatrutide
URL:https://www.wiremeridian.com/c/eli-lilly/retatrutide
STATUS:TENTATIVE
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR